Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Leukemia 28Lymphoma 10Burkitt Lymphoma 9Leukemia, Promyelocytic, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Erythroblastic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Cardiotoxicity 1Blast Crisis 1

Interventions

merphos 1azathiopurine 1arsenous acid 1Tretinoin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Cytarabine 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Childhood Acute Promyelocytic Leukemia With PML-RARA × Mercaptopurine × Clear all
NCT00866918 2022-10-25

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Children's Oncology Group

Phase 3 Completed
106 enrolled 14 charts
MyeloidOther hematologic neoplasm

Childhood Acute Promyelocytic Leukemia With PML-RARA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡